High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. - Wikidata - awgldk - TriplyDB

High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation.

High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation.

http://www.wikidata.org/entity/Q37066329

about

Delivering care to long-term adult survivors of hematopoietic cell transplantation.Late effects of blood and marrow transplantation.Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study Late cardiovascular complications after hematopoietic cell transplantation.Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation.Contrast enhanced cardiac CT reveals coronary artery disease in 45% of asymptomatic allo-SCT long-term survivors.Vascular injury in cancer survivors.Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation.Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor.How I treat late effects in adults after allogeneic stem cell transplantation.Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation.Gallstones in pediatric hematopoietic cell transplant survivors with up to 40 years of follow-up.Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity.Adverse Fat Depots and Marrow Adiposity Are Associated With Skeletal Deficits and Insulin Resistance in Long-Term Survivors of Pediatric Hematopoietic Stem Cell Transplantation.Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction.Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation.Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantation.Cardiovascular disease in survivors of hematopoietic cell transplantation.Lipid profiles of pediatric hematopoietic stem cell transplant survivors.Metabolic syndrome in patients with hematological diseases.How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.Metabolic syndrome in children and adolescents: Old concepts in a young population.Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.The cancer is over, now what?: Understanding risk, changing outcomes.Metabolic syndrome in hematologic malignancies survivors: a meta-analysis.Nephrolithiasis in pediatric hematopoietic cell transplantation with up to 40 years of follow-up.A comparison between metabolic syndrome post-hematopoietic stem cell transplantation and spontaneously occurring metabolic syndrome.Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW Australia.Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors' cohort: A comparison with controls from the French population.Cost-effectiveness of a lifestyle modification program in long-term survivors of hemopoietic stem cell transplantation.The metabolic syndrome and its components in pediatric survivors of allogeneic hematopoietic stem cell transplantation.Chemotherapy alone or HSCT after reduced-intensity conditioning for patients with malignant hematologic diseases are not associated to metabolic syndrome: a cross-sectional observational study.Bone Marrow Cell Transplant From Donors With Cardiovascular Risk Factors Increases the Pro-atherosclerotic Phenotype in the Recipients.Impact of a lifestyle modification program on the metabolic syndrome and associated risk factors in long-term survivors of stem cell transplantation.

P2860

Q27021501-9B708F6B-3497-4324-B071-9C28B7C8B8B2 Q33574136-A5A04F70-286E-432B-A2A2-55FE4C4C5D77 Q33585366-9BE9EE97-177F-46AA-BC8B-1E5EB3FF3A70 Q33605306-077FA846-0D35-4FFA-B555-F49D69C01B3E Q33926274-C609FFFB-6223-4355-9639-C217227507C4 Q34111301-20157BB4-945F-4DB4-A0AF-E4BF37D22A46 Q34211238-65C5B2B0-403A-4A17-B297-99270DF1661C Q34288406-8AB0D6A3-DC5B-4654-9231-DDEECD0059F4 Q34451605-0E0581F4-B87A-46EE-972F-01811C2EE7A8 Q34707208-319EFF06-890F-49FC-ADEB-561562097309 Q35184667-5EE5A8E8-A8B1-4F41-83F8-6812E4A3A6F2 Q35556074-86920DFE-174D-4D35-B205-BB382D0B5E4D Q35600025-87DBDA86-61DA-479F-BB25-7226FDB3BA87 Q35849275-0E0CB1F6-95BD-4605-AC02-57DEC617944F Q35967618-1D24064F-F7B9-417E-8E7A-027CE5081293 Q36440055-07B3C481-7116-41BE-9264-C52FCA05229E Q36999204-7F72F1B6-40B7-42B1-A13B-DDC274552FA5 Q37104278-D0D95679-113C-4EB0-A07A-10EDFC186FB4 Q37213203-773E7C83-0F87-4926-9349-8B2D032760D7 Q37247613-79DDA2D9-F9BE-4B02-B2C3-CD8695B69976 Q37347871-9BF3022B-4049-4EE1-86BE-812B6CB91840 Q37624268-FED5BFCB-DDBF-416E-BC9E-744E7172AE03 Q37993496-44A4B808-8E47-48D6-A03D-F9E1FCB4F124 Q38044776-48BA734F-D079-47E0-A96F-6CF1E3DA961A Q38797551-451BE99D-E0A9-4D01-800F-269AD407AF5A Q38853283-DB07FB73-517F-4F5B-958A-8FFC2B43960D Q38933848-10A3292C-B1AA-4ECF-BC57-174E23A5D9B6 Q39046196-771FF3D0-4427-4326-A71B-FE8F47D30C77 Q39749166-F9EA6FA1-FABC-40F4-B79A-7DF2EA1CC520 Q41730597-C8842B85-E6A8-4661-9A86-E8364D9538BC Q43931110-2DA70538-CFCB-4566-BB58-3F7546EF292D Q44235234-89D4BBDD-3F37-4D7B-BA56-0CE3E84D76B0 Q47276614-E705D3CD-3943-4EBA-AC25-65D78DF60F56 Q47551124-E379259E-C270-4500-B6EF-591B87455697 Q48175219-C14E886F-17DC-4D8E-9F33-8C339C84EE1A Q50979974-9C2A536E-8E67-4F6C-B4C5-DE403769FA51 Q51320628-A9FF6EFE-4B62-43FF-8CFC-7640612FCA7F Q53065775-032598E3-6AF6-4C7B-99E1-2CFC8017B4C5 Q53241214-8F76F59B-B78F-4671-90BB-3E993009A84A

P2860

High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation.

http://www.wikidata.org/entity/Q37066329

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

High prevalence of metabolic s ...... opoietic cell transplantation.

@en

High prevalence of metabolic s ...... opoietic cell transplantation.

@nl

type

label

High prevalence of metabolic s ...... opoietic cell transplantation.

@en

High prevalence of metabolic s ...... opoietic cell transplantation.

@nl

prefLabel

High prevalence of metabolic s ...... opoietic cell transplantation.

@en

High prevalence of metabolic s ...... opoietic cell transplantation.

@nl

P1433

Q37066329-C965A54B-6F6F-42E2-9226-825CD05760F2

P1476

Q37066329-65A8C116-57CD-4409-A878-92324B817539

P2093

Q37066329-115BEB26-58C1-4CC6-9366-E2755E1D9ECD

Q37066329-14872719-8328-483D-BCDE-99E9806C5F56

Q37066329-557A5AF3-7BF6-4F62-84F4-06054215C243

Q37066329-68FB8016-ADB8-4B3F-8CE7-BC2EA416B963

Q37066329-694411DF-8411-45F1-BA86-B9EBA253B96F

Q37066329-86CCB52A-D14C-4BDE-87B6-2C79E4AC2E44

Q37066329-9A84CD4C-F8AA-49C0-9E25-75C71B29C3C7

Q37066329-B74A9B49-4F69-4BC8-921E-0D494EA0BCCA

Q37066329-CC186F5E-32EC-407B-950C-917522E94F8C

Q37066329-CC794DD1-A4BD-4006-9E37-168422D17E7F

P2860

Q37066329-0501D50C-5790-4C04-9F81-7E31414626F7

Q37066329-2F07E909-3F77-4DF4-8BF5-C6B2F907747F

Q37066329-30067F75-89D2-4E83-BAF5-ED30C6C4AA23

Q37066329-42833871-4F99-4895-8ED1-D2633326D2A2

Q37066329-49E47B7A-6AE8-4B44-9EFD-A629F2D17D38

Q37066329-4A0BCE18-8588-43AC-84A6-B0F1AD11B024

Q37066329-53DFD33A-DC8F-4041-8BA7-EED96009DDBF

Q37066329-5AAC5CB4-20BF-4BB5-A008-64DECCA120F9

Q37066329-6202C048-42EF-433C-8890-DD905A396A89

Q37066329-6B4F2F34-6B31-420B-871E-0A235AB0A8B6

P2888

Q37066329-AF0CED28-4019-44BF-9BED-51194729FEFB

P304

Q37066329-69885590-B10E-4292-AED2-43902F5FB08B

P31

Q37066329-33019238-0823-40C9-98A0-4D7FCEC806D2

P356

Q37066329-61BC2FC6-2507-4DD0-B923-FEBEF45363C3

P407

Q37066329-EDD4E935-B22A-479A-B7EB-035BEE5376B7

P433

Q37066329-57D59659-7CEA-4DD2-B5BE-1B690C5E59DB

P478

Q37066329-817178E3-CCF6-445F-9F55-F99E374F2DD8

P577

Q37066329-CE6B7D97-C5D3-47DD-A006-000B2F2C6D0E

P5875

Q37066329-3E51095B-F442-47FA-BFAD-60F640F3A637

P698

Q37066329-B91752AD-516F-47F4-9999-98654E647BC7

P921

Q37066329-E741A413-B489-4914-B81D-B4838D3B2CF1

P932

Q37066329-49CAF181-CE9E-4C3F-A5CE-AE5C79CC78F1

P356

P1433

Bone Marrow Transplantation

P1476

High prevalence of metabolic s ...... opoietic cell transplantation.

@en

P2093

K K Ness

http://www.w3.org/2001/XMLSchema#string

K S Baker

http://www.w3.org/2001/XMLSchema#string

L J Burns

http://www.w3.org/2001/XMLSchema#string

L Johnston

http://www.w3.org/2001/XMLSchema#string

M Arora

http://www.w3.org/2001/XMLSchema#string

M E Flowers

http://www.w3.org/2001/XMLSchema#string

M Jagasia

http://www.w3.org/2001/XMLSchema#string

N S Majhail

http://www.w3.org/2001/XMLSchema#string

P A Carpenter

http://www.w3.org/2001/XMLSchema#string

P J Martin

http://www.w3.org/2001/XMLSchema#string

P2860

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Transplant-associated hyperglycemia: a new look at an old problem.

The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures.

Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study.

Steroid sparing in kidney transplantation: changing paradigms, improving outcomes, and remaining questions.

Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.

P2888

P304

49-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2008.263

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23191180

http://www.w3.org/2001/XMLSchema#string

P698

18724397

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

2628412

http://www.w3.org/2001/XMLSchema#string